Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review.

Published in: Yonsei medical journal (2024)

This meta-analysis showed that 5 mg rosuvastatin/10 mg ezetimibe had largely comparable lipid-modifying efficacy and tolerability as 20 mg rosuvastatin.

Keyphrases

systematic review
open label
high intensity
helicobacter pylori
meta analyses
helicobacter pylori infection
randomized controlled trial
clinical trial
fatty acid